Parkinson's disease

Acta Clinica Croatica

Volumn 48, Issue 3, 2009, Pages 377-380

  Béné, Raphael ^a   Antić, Sonja ^a   Budišić, Mislav ^a   Lisak, Marijana ^a   Trkanjec, Zlatko ^a   Demarin, Vida ^a   Podobnik Šarkanji, Slava ^b  

^a MINISTRY OF HEALTH AND SOCIAL WELFARE   (Croatia)

^b Podobnik Outpatient Clinic   (Croatia)

Author keywords

Parkinson disease diagnosis; Parkinson disease etiology; Parkinson disease therapy

Indexed keywords

AMANTADINE; BENSERAZIDE; CARBIDOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPA; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; PRAMIPEXOLE; ROPIRINILE; SELEGILINE; TOLCAPONE; UNCLASSIFIED DRUG;

ARTICLE; BRADYKINESIA; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; INCIDENCE; MENTAL INSTABILITY; PARKINSON DISEASE; PATHOPHYSIOLOGY; RIGIDITY; TREMOR;

HUMANS; PARKINSON DISEASE;

EID: 74049145203     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. BERNHEIMER H, BERKMAYER W, HORNYKIEWICZ O, JELLINGER K, SEITELBERGER F. Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 1973;20:415-55.
2. BRAAK H, GHEBREMEDHIN E, RUB U, BRATZKE H, Del TREDICI K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318:121-34.
3. LANGSTON JW. The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann Neurol 2006;59:591-6.
4. DOUBLE KL, ROWE DB, HAYES M, CHAN DK, BLACK-IE J, CORBETT A, et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol 2003;60:545-9.
5. GUTTMAN M, SLAUGHTER PM, THERIAULT ME, Be-BOER DP, NAYLOR CD. Burden of parkinsonism: a population-based study. Mov Disord 2003;18:313-9.
6. GUTTMAN M, KISH SJ, FURUKAWA Y. Current concepts in the diagnosis and management of Parkinson's disease. CMAJ 2003;168:293-301.
7. JANKOVIC J, TOLOSA E. Parkinson's disease and movement disorders. Philadelphia: Lippincott Williams and Wilkins, 2007.
8. BALLARD PA, TETRUD JW, LANGSTON JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) : seven cases. Neurology 1985;35:949-56.
9. BUDIŠIĆ M, BOŠNJAK J, LOVRENČIĆ-HUZJAN A, STRINEKA M, BENE R, AŽMAN D, BEDEK D, TRKAN-JEC Z, DEMARIN V. Transcranial sonography in the evaluation of pineal lesions: two-year follow up study. Acta Clin Croat 2008;47:205-10.
10. JANKOVIC J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-76.
11. GIBB WR, LEES AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-52.
12. HUGHES AJ, DANIEL SE, KILFORD L, LEES AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
13. GELB DJ, OLIVER E, GILMAN S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-9.
14. LEES AJ, KATZENSCHLAGER R, HEAD J, BEN SHLO-MO Y Ten-year follow-up of three differential treatments in de novo YD: a randomized trial. Neurology 2001;57:1687-94.
15. GOETZ CG, KOLLER WC, POEWE W, RASCOL O, SAM-PAIO C Management of Parkinson's disease: an evidencebasedreview. MovDisord 2002;17(Suppl 4):S1-S166.
16. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameters: initial therapy of Parkinson's disease. Neurology 1993;43:1296-7.
17. NUTT JG, WOOTEN GF. Diagnosis and initial management of Parkinson's disease. N Engl J Med 2005;353:1021-7.